The University of Alcala was founded in 1499 and is one of the oldest universities in Europe. Several distinguished members of the Spanish culture have passed through its classrooms, such as Lope de Vega, Francisco de Quevedo, Tirso de Molina, and Antonio de Nebrija.
The Master in Therapeutic Targets in Cellular Signaling: Research and Development is one of more than 50 masters at Alcala University. This master of excellence only admits 20 students and is characterized by excellent teaching and personalized attention. The teachers’ proximity and expertise in the subjects taught is a significant advantage.
This master covers the entire research process; it begins with basic research in the laboratory. It focuses on searching for therapeutic targets, continues with the design and production of drugs, and ends with clinical research on investigational products.
This master’s degree also includes clinical research in its curriculum, and two of our employees carried out an internship at AKRN before obtaining permanent employment. In our experience, the students who have completed the Master in Therapeutic Targets have a robust scientific background, making them highly qualified for a career in the medical device industry.
We are thankful to collaborate with the University of Alcala for this master’s degree and hope to offer more internships to brilliant students in the next year.